Alyssa Althoff, BS; Jourdan M. Cancienne, MD; Minton T. Cooper, MD; Brian C. Werner, MD
J Foot Ankle Surg. 2018 Mar – Apr;57(2):269-272.
Doi: 10.1053/j.jfas.2017.09.006. Epub 2017 Dec 15.
Summary by Daniel O. Corr, BS
Total ankle arthroplasty (TAA) continues to be a procedure performed with increased frequency. As anatomic and biomechanical implant design has developed, the procedure offers an increasingly efficient means of preserving joint motion and functionality for patients diagnosed with end-stage arthritis of the ankle versus a joint fusion procedure.1-5 While the prospects of this constantly developing procedure are enticing, it also brings with it the increased possibility of postoperative periprosthetic joint infection (PJI).6 As with any joint arthroplasty procedure, it is necessary to understand the patient factors associated with increased risk of PJI. Specifically for TAA it is imperative to gather more patient data from larger patient cohorts as the procedure becomes more common, as previous studies have often been limited by the size of their patient pools.7
Althoff et al. performed a large retrospective evaluation of TAAs from 2005 to 2012 using a national insurance claim-based database. The insurance database was used to identify patient demographic risk factors for PJI within 3 and 6 months of the index procedure. This database includes patient demographic and procedure volume data from several different insurers including Medicare and private insurers. Using CPT and ICD-9 procedure codes, the authors identified 6,977 patients undergoing primary TAA while excluding those undergoing revision procedures.
The study found a 6-month infection rate of 4.2% and several independent patient risk factors for PJI, which were largely similar for both the 3 month and 6 month endpoint. Risk factors for the primary endpoint of 6-month infection included BMI >30 (OR=1.47; 95% CI 1.15-1.87), BMI <19 (OR=2.67; 95% CI 1.07-6.67), tobacco use (OR=1.44; 95% CI 1.08-1.92), inflammatory arthritis (OR=1.67; 95% CI 1.28-2.18), peripheral vascular disease (OR=2.46; 95% CI 1.87-3.22), and hypothyroidism (OR=1.32; 95% CI 1.03-1.69).
The authors conclude that it is imperative to evaluate patients and understand these risk factors for infection in the preoperative setting, especially since surgical site infection associated with TAA has been reported to result in implant failure 80.6% of the time.6 The study, while presenting a large cohort, is limited in its use of an administrative database. Operative time, surgical approach, and tourniquet time could not be assessed as the data was not available. In addition, the 6 month endpoint may have excluded additional viable patients, but was used because the authors felt less certain that longer-term infection diagnosis could be directly attributed to the primary TAA.
- Easley ME, Adams SB, Hembree WC, DeOrio JK. Results of total ankle arthroplasty. J Bone Joint Surg Am 93:1455–1468, 2011.
- Gougoulias N, Khanna A, Maffulli N. How successful are current ankle replacements? A systematic review of the literature. Clin Orthop Relat Res 468:199–208, 2010.
- Jiang JJ, Schipper ON, Whyte N, Koh JL, Toolan BC. Comparison of perioperative complications and hospitalization outcomes after ankle arthrodesis versus total ankle arthroplasty from 2002 to 2011. Foot Ankle Int 36:360–368, 2015.
- Raikin SM, Rasouli MR, Espandar R, Maltenfort MG. Trends in treatment of advanced ankle arthropathy by total ankle replacement or ankle fusion. Foot Ankle Int 35:216–224, 2014.
- Stavrakis AI, SooHoo NF. Trends in complication rates following ankle arthrodesis and total ankle replacement. J Bone Joint Surg 98:1453–1458, 2016.
- Glazebrook MA, Arsenault K, Dunbar M. Evidence-based classification of complications in total ankle arthroplasty. Foot Ankle Int 30:945–949, 2009.
- Kessler B, Sendi P, Graber P, Knupp M, Zwicky L, Hintermann B, Zimmerli W. Risk factors for periprosthetic ankle joint infection: a case-control study. J Bone Joint Surg Am 94:1871–1876, 2012.